image
Oculis Holding AG OCS
Healthcare - Biotechnology - NASDAQ - CH
Watchlist
$ 19.28
-1.03 %
$ 1.05 B
Market Cap
-6.67
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
342.91%
EBIT Estimate
--43.24%
Net Income Estimate
49.75%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Oculis Holding AG
image
OCS has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart OCS

image
$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart OCS

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart OCS

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)($80.0m)($80.0m)($90.0m)($90.0m)20232023202420242025202520262026202720272028202820292029